Xu et al. [104] recently identified ZNF397 as essential for maintaining AR-driven luminal lineage in PCa, and its deficiency leads to a transition to a TET2-driven lineage plastic state, contributing to resistance to AR-targeted therapies. The gene discussed is AR; the disease is posterior cortical atrophy.